Autori: Tafelmeier Maria
Naslov | Sacubitril/valsartan for treatment of symptomatic non-obstructive hypertrophic cardiomyopathy: a randomised, controlled, phase II clinical trial (SILICOFCM) (Meeting Abstract) |
Autori | Velicki Lazar U ![]() ![]() ![]() ![]() ![]() |
Info | EUROPEAN HEART JOURNAL, (2023), vol. 44 br. , Suppl. 2, str. - |
Projekat | Horizon 2020 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy (Meeting Abstract) |
Autori | Velicki Lazar U ![]() ![]() |
Info | EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, (2020), vol. 19 br. 1_SUPPL, Suppl. 1_, str. S43-S44 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy (Article) |
Autori | Tafelmeier Maria Baessler Andrea Wagner Stefan Unsoeld Bernhard Preveden Andrej P ![]() ![]() ![]() |
Info | CLINICAL CARDIOLOGY, (2020), vol. 43 br. 5, str. 430-440 |
Projekat | European Union's Horizon 2020 Research and Innovation Programme [777204] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|